Profil
Taylor Boyd is Chief Business Officer at Avalo Therapeutics, Inc. since 2025.
Former roles include Chief Business Officer & Executive VP at Abzena Ltd. and Investor Relations Contact at Oxford Biomedica Plc from 2022 to 2024.
Education includes graduate studies at Wake Forest University and undergraduate studies at North Carolina State University.
Aktiva positioner av Taylor Boyd
| Företag | Position | Start |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Företagsledare/Principal | 2025-10-01 |
Tidigare kända positioner av Taylor Boyd
| Företag | Position | Slut |
|---|---|---|
| OXFORD BIOMEDICA PLC | Offentlig kommunikationskontakt | 2024-01-01 |
| ABZENA PLC | Företagsledare/Principal | - |
Taylor Boyds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Abzena Ltd.
Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
















